FDA Approved: NAMZARIC — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Namzaric (memantine hydrochloride and donepezil hydrochloride) submitted by Allergan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• NAMZARIC (Memantine hydrochloride and donepezil hydrochloride)

Snippet

SUPPL AP for NAMZARIC (MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE)